Ville T Männistö1, Marko Simonen1, Jenni Hyysalo2, Pasi Soininen3,4, Antti J Kangas3,4, Dorota Kaminska5, Ananda K Matte5, Sari Venesmaa6, Pirjo Käkelä6, Vesa Kärjä7, Johanna Arola8, Helena Gylling5,9, Henna Cederberg1, Johanna Kuusisto1, Markku Laakso1, Hannele Yki-Järvinen2, Mika Ala-Korpela3,4,10, Jussi Pihlajamäki5,11. 1. Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. 2. Department of Medicine, University of Helsinki, Helsinki and Minerva Medical Research Institute, Helsinki, Finland. 3. NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland. 4. Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland. 5. Department of Clinical Nutrition, University of Eastern Finland, Kuopio, Finland. 6. Department of Surgery, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. 7. Department of Pathology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland. 8. Department of Pathology, The Laboratory of Helsinki University Central Hospital, Helinski, Finland. 9. Department of Medicine, Division of Internal Medicine, University of Helsinki, Helsinki, Finland. 10. Computational Medicine, School of Social and Community Medicine & Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK. 11. Clinical Nutrition and Obesity Center, Kuopio University Hospital, Kuopio, Finland.
Abstract
BACKGROUND & AIMS: Levels of ketone bodies have been reported to be both increased and decreased in individuals with non-alcoholic fatty liver disease. We investigated whether the metabolism of ketone bodies is different in simple steatosis and in non-alcoholic steatohepatitis (NASH). METHODS: Serum low molecular weight molecules including ketone bodies were measured using high-throughput proton (1H) nuclear magnetic resonance in 116 (76 categorized unequivocally to those with normal liver, simple steatosis or NASH) morbidly obese individuals [age 47.3 ± 8.7 (mean ± SD) years, body mass index 45.1 ± 6.1 kg/m(2) , 39 men and 77 women] with histological assessment of NASH and analysis of gene expression in the liver. Finally, we correlated β-hydroxybutyrate (β-OHB) levels with NASH predicting score in Metabolic Syndrome in Men Study (METSIM) population study (n = 8749 non-diabetic men). RESULTS: Levels of ketone bodies were lower in individuals with NASH compared to individuals with simple steatosis (P = 0.004 and P = 0.018 for β-OHB and acetoacetate respectively). Lower levels of β-OHB were associated with the NASH predicting score in the METSIM study (P = 0.001). Liver inflammation correlated with mRNA expression of genes regulating ketolysis in the liver (Spearman correlation 0.379-0.388, P < 0.0006 for ACAT1, ACSS2 and BDH1). CONCLUSION: Lower levels of ketone bodies in individuals with NASH compared to individuals with simple steatosis suggest a decrease in ketone body metabolism in NASH.
BACKGROUND & AIMS: Levels of ketone bodies have been reported to be both increased and decreased in individuals with non-alcoholic fatty liver disease. We investigated whether the metabolism of ketone bodies is different in simple steatosis and in non-alcoholic steatohepatitis (NASH). METHODS: Serum low molecular weight molecules including ketone bodies were measured using high-throughput proton (1H) nuclear magnetic resonance in 116 (76 categorized unequivocally to those with normal liver, simple steatosis or NASH) morbidly obese individuals [age 47.3 ± 8.7 (mean ± SD) years, body mass index 45.1 ± 6.1 kg/m(2) , 39 men and 77 women] with histological assessment of NASH and analysis of gene expression in the liver. Finally, we correlated β-hydroxybutyrate (β-OHB) levels with NASH predicting score in Metabolic Syndrome in Men Study (METSIM) population study (n = 8749 non-diabetic men). RESULTS: Levels of ketone bodies were lower in individuals with NASH compared to individuals with simple steatosis (P = 0.004 and P = 0.018 for β-OHB and acetoacetate respectively). Lower levels of β-OHB were associated with the NASH predicting score in the METSIM study (P = 0.001). Liver inflammation correlated with mRNA expression of genes regulating ketolysis in the liver (Spearman correlation 0.379-0.388, P < 0.0006 for ACAT1, ACSS2 and BDH1). CONCLUSION: Lower levels of ketone bodies in individuals with NASH compared to individuals with simple steatosis suggest a decrease in ketone body metabolism in NASH.
Authors: Caroline E Geisler; Susma Ghimire; Randy L Bogan; Benjamin J Renquist Journal: Am J Physiol Gastrointest Liver Physiol Date: 2019-02-15 Impact factor: 4.052
Authors: David E Stec; Darren M Gordon; Jennifer A Hipp; Stephen Hong; Zachary L Mitchell; Natalia R Franco; J Walker Robison; Christopher D Anderson; Donald F Stec; Terry D Hinds Journal: Am J Physiol Regul Integr Comp Physiol Date: 2019-09-04 Impact factor: 3.619
Authors: Vanessa D de Mello; Ashok Matte; Alexander Perfilyev; Ville Männistö; Tina Rönn; Emma Nilsson; Pirjo Käkelä; Charlotte Ling; Jussi Pihlajamäki Journal: Epigenetics Date: 2017-02-23 Impact factor: 4.528
Authors: Jacob T Mey; Melissa L Erickson; Christopher L Axelrod; William T King; Chris A Flask; Arthur J McCullough; John P Kirwan Journal: Am J Physiol Endocrinol Metab Date: 2020-05-12 Impact factor: 4.310